Back to Blog
Hormones 9 min read

Vaginal Dryness, Painful Sex, and Frequent UTIs in Perimenopause: What Is Happening Down There?

Vaginal Dryness, Painful Sex, and Frequent UTIs in Perimenopause: What Is Happening Down There? — SomneX Health

Vaginal dryness, painful sex, or frequent UTIs? Learn how perimenopause changes vaginal tissue—and how local estradiol and hormone therapy may help.

Your Vagina Did Not Suddenly Become Dramatic

If sex suddenly feels more like sandpaper than pleasure—or you keep getting what feels like one urinary tract infection after another—you are not imagining it.

During perimenopause, hormone levels begin to fluctuate and eventually decline. Most women hear plenty about hot flashes, night sweats, mood changes, and irregular periods. What often gets left out of the conversation is what those same hormone changes can do to the vagina, vulva, clitoris, bladder, and urethra.

Dryness, burning, irritation, painful sex, decreased sensation, urinary urgency, and recurrent UTIs may all be connected.

These symptoms are common, but they should not be dismissed as something you simply have to tolerate with age. Your vaginal tissue is living, hormone-responsive tissue—and when its hormonal support changes, the tissue changes too.

What Happens to Vaginal Tissue During Perimenopause?

Estrogen helps maintain the thickness, elasticity, moisture, blood flow, acidity, and overall health of vaginal and urinary tissues.

As estrogen begins fluctuating and declining during perimenopause, the tissues may gradually become thinner and more fragile, drier and less naturally lubricated, less elastic, more easily irritated, more likely to develop tiny tears during sex, more sensitive to soaps, clothing, exercise, and friction, and less protected against certain bacteria.

Blood flow to the vulva and vagina may also decrease. The vaginal microbiome can change, protective Lactobacillus bacteria may decline, and vaginal pH may rise. In plain English: the tissue becomes more delicate, and the environment becomes less protective.

This combination of vaginal, vulvar, sexual, and urinary symptoms is called genitourinary syndrome of menopause, or GSM. Despite the name, GSM can begin during perimenopause—before your periods have stopped completely.

Unlike some hot flashes that eventually improve, untreated GSM often persists or progresses. Fortunately, it is also very treatable.

Symptoms Are Not Limited to Vaginal Dryness

Vaginal dryness may be the symptom everyone recognizes, but hormonal tissue changes can show up in several ways.

You may notice burning, itching, or irritation; pain at the vaginal opening; pain with penetration or deeper discomfort during sex; feeling sore for hours or days after sex; small tears or light spotting after intercourse; decreased lubrication; reduced clitoral sensation; more difficulty becoming aroused or reaching orgasm; urinary urgency or frequency; burning with urination; urine leakage; or frequent or recurrent UTIs.

Some women describe it as feeling "raw." Others say sex suddenly feels tight, sharp, or uncomfortable even though it was never painful before.

Please do not let anyone hand you a travel-size tube of lubricant and call the case closed. Lubrication can help with friction, but it does not always treat the underlying tissue changes.

Why Can Perimenopause Make Sex Painful?

Healthy vaginal tissue is meant to stretch, expand, lubricate, and respond to stimulation. When the tissue becomes thinner, drier, and less elastic, friction increases—and friction against fragile tissue can hurt.

Pain can then create another problem: anticipation.

If your brain expects sex to hurt, your pelvic floor muscles may automatically tighten to protect you. That tightening can make penetration even more uncomfortable, creating a frustrating cycle: pain leads to guarding, guarding creates more tension, and more tension creates more pain.

This is why painful sex may require more than one intervention. Restoring the tissue is important, but some women also benefit from pelvic-floor physical therapy, treatment for an infection or vulvar condition, changes in medication, or support for arousal and sexual response.

Sex should not become something you dread, avoid, or endure.

What Do Hormone Changes Have to Do With Frequent UTIs?

The vagina, urethra, and bladder are close neighbors—and they share some of the same hormonal influences.

As estrogen declines, tissues surrounding the urethra can become thinner, drier, and more easily irritated. Changes in vaginal pH and protective bacteria may also make it easier for unwanted bacteria to reach the urinary tract.

That can contribute to true recurrent UTIs. However, GSM itself can also cause burning, urgency, and frequency that feel very similar to a UTI, even when a urine culture is negative.

This is one reason repeated urinary symptoms deserve a closer look. We need to determine whether you have a confirmed bacterial infection, hormone-related urinary tissue changes, pelvic-floor dysfunction, bladder irritation, another vaginal or vulvar condition, or a combination of several factors.

For perimenopausal and postmenopausal women with recurrent UTIs, current urology guidelines recommend local low-dose vaginal estrogen when appropriate because it can reduce the risk of future infections—not merely cover up the symptoms.

Local Vaginal Estradiol: Treating the Tissue Where It Needs Help

Local vaginal estradiol is one of the most effective treatments for hormone-related vaginal and urinary tissue changes.

Depending on the product, it may be available as a vaginal cream, small vaginal tablet or insert, or vaginal ring.

Local estradiol works directly within the vaginal and surrounding urinary tissues. It can help improve tissue thickness, elasticity, moisture, blood flow, vaginal pH, and the protective vaginal environment.

Over time, this may improve vaginal dryness, burning and irritation, pain with sex, small tears or post-sex soreness, urinary urgency and burning, and recurrent UTIs.

Low-dose vaginal estradiol is not the same as taking full-dose systemic estrogen for hot flashes or whole-body symptoms. Systemic absorption is generally low, although treatment still needs to be individualized—especially for anyone with unexplained bleeding, a history of estrogen-sensitive cancer, or other relevant medical concerns.

The 2025 multidisciplinary GSM guideline supports local low-dose vaginal estrogen for vulvovaginal symptoms and recurrent UTIs when clinically appropriate.

What About Testosterone Cream on the Inner Labia or Clitoris?

Testosterone is not only a "male hormone." Women naturally produce testosterone, and female genital tissues are responsive to androgens too.

Androgen receptors have been identified throughout vulvar and vaginal tissues, including the labia, vaginal wall, blood vessels, smooth muscle, and clitoral structures. Research has found particularly notable androgen-receptor expression in the labial and vulvar tissues. Your vulvovaginal tissues are definitely not estrogen-only real estate.

For carefully selected patients, a provider may prescribe a very small amount of compounded testosterone cream for external application to the inner labial or clitoral tissues. Depending on the woman and the cause of her symptoms, treatment may be considered as part of a broader plan addressing vulvar tissue health, clitoral sensitivity, arousal, sexual sensation, libido, and orgasm difficulty.

However, testosterone is not interchangeable with vaginal estradiol, and it should not be presented as the standard first-line treatment for recurrent UTIs or all GSM symptoms. Testosterone products are not currently FDA-approved for women in the United States, and evidence for routine vaginal testosterone treatment remains limited. The current GSM guideline found insufficient evidence to recommend vaginal or systemic testosterone as a routine GSM treatment.

That does not mean testosterone has no role. It means treatment must be individualized, prescribed thoughtfully, and monitored appropriately. This is not a "borrow someone's hormone cream and see what happens" situation.

Do You Need Both Vaginal Estradiol and Testosterone?

Sometimes—but not automatically.

Local vaginal estradiol and testosterone can address different parts of the clinical picture. A woman with dryness, fragile tissue, painful sex, and recurrent UTIs may benefit from local vaginal estradiol. A woman who also has decreased desire, reduced clitoral sensation, impaired arousal, or orgasm changes may need a more comprehensive hormonal and sexual-health evaluation.

Some women may use systemic hormone therapy and still require local vaginal treatment. Systemic estrogen does not always provide enough support to the vulvovaginal and urinary tissues.

The correct plan depends on your symptoms, exam findings, medical history, medications, hormone pattern, pelvic-floor function, and goals—not one isolated hormone number.

At SomneX Health, we do not simply chase laboratory values. We treat the patient, the pattern, and the tissue.

What Else Can Help Vaginal Dryness and Painful Sex?

Hormonal treatment may be important, but it is not the only tool available.

A comprehensive plan may also include a quality vaginal moisturizer used routinely, lubricant during sexual activity, avoiding fragranced washes, wipes, sprays, and douches, pelvic-floor physical therapy, gradual vaginal dilator therapy when appropriate, more time for arousal before penetration, reviewing medications that may affect lubrication or sexual response, testing for vaginal or urinary infections, evaluating vulvar skin conditions, and addressing sleep, stress, metabolic health, and relationship factors.

A lubricant helps reduce friction during sex. A vaginal moisturizer is used regularly to help maintain moisture between sexual encounters. They are helpful, but they serve different purposes—and neither should replace an evaluation when symptoms are persistent or worsening.

When Should You Be Evaluated?

Do not assume every vaginal or urinary symptom is "just hormones."

Schedule an evaluation if you experience persistent or worsening vaginal pain, bleeding after sex, unexplained vaginal bleeding, new sores, skin changes, or lesions, unusual discharge or odor, fever, chills, back pain, or blood in the urine, repeated UTI symptoms, pain that prevents penetration, or symptoms that do not improve with moisturizers or lubricants.

Painful sex can result from hormone-related tissue changes, but infections, vulvar disorders, pelvic-floor dysfunction, endometriosis, medication effects, and other conditions may cause similar symptoms.

Frequently Asked Questions

Can vaginal dryness begin before menopause? Yes. Vaginal and vulvar symptoms can begin during perimenopause while you are still having periods. Hormones do not wait for your official menopause date before they begin fluctuating.

Can low estrogen cause frequent UTIs? Declining estrogen can change the vaginal and urinary tissues, vaginal pH, and protective bacterial environment. These changes may increase the risk of recurrent UTIs and may also cause UTI-like symptoms without an infection.

Will lubricant fix painful sex? Lubricant may reduce friction, but it does not rebuild thin, fragile, hormone-deprived tissue. If sex remains painful, you deserve a complete evaluation.

Is local vaginal estradiol the same as systemic HRT? No. Local vaginal estradiol is placed directly in the vagina and generally produces much lower systemic exposure than hormone therapy used to treat whole-body symptoms such as hot flashes.

Can testosterone cream be applied to the clitoral or labial tissues? In selected patients, a clinician may prescribe a carefully measured amount of compounded testosterone cream for external vulvar, inner-labial, or clitoral application. This is an individualized, off-label use and should be prescribed and monitored by a knowledgeable healthcare provider.

References & Clinical Resources

  1. 1.Kaufman MR, Ackerman AL, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. Journal of Urology. 2025;214(3):242–250. View source
  2. 2.American Urological Association, Canadian Urological Association, and SUFU. Recurrent Uncomplicated Urinary Tract Infections in Women Guideline. Updated 2025. View source
  3. 3.The North American Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement. Menopause. 2020;27(9):976–992. View source
  4. 4.Danan ER, et al. Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause: A Systematic Review. Annals of Internal Medicine. 2024;177(10):1400–1414. View source
  5. 5.Rahn DD, et al. Vaginal Estrogen for Genitourinary Syndrome of Menopause: A Systematic Review. Obstetrics & Gynecology. 2014;124(6):1147–1156. View source
  6. 6.Palacios S. Expression of Androgen Receptors in the Structures of Vulvovaginal Tissue. Menopause. 2020;27(11):1336–1342. View source
  7. 7.Parish SJ, Simon JA, Davis SR, et al. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Sexual Medicine. 2021;18(5):849–867. View source
Take the Next Step

You Do Not Have to Accept Pain, Dryness, or Recurrent UTIs as Your New Normal

Vaginal dryness, painful sex, decreased sensation, and frequent urinary symptoms are not embarrassing side notes of perimenopause. They are legitimate medical concerns that can affect your comfort, confidence, relationships, sleep, and quality of life. At SomneX Health, we evaluate the full pattern—including hormonal changes, vaginal and urinary tissue health, sexual function, medications, sleep, metabolic health, and the factors that may be connecting your symptoms. You deserve more than "use more lubricant" or "that is just part of getting older."

Book a Consultation